Marshall Wace North America’s Scansource SCSC Stock Holding History

Marshall Wace North America’s Portfolio SCSC Stock Details SCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,688	Closed	-$310K	–	1319
2018 Q2	$310K	Sell	7,688 -5,590	-42%	-$211K	﹤0.01%	1179
2018 Q1	$472K	Buy	+13,278	New	+$454K	﹤0.01%	1166

Other funds holding SCSC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Marshall Wace North America's SCSC Position: Q3 2018 in Review

Marshall Wace North America sold out of Scansource (SCSC) in Q3 2018, closing a stake of 7,688 shares — an estimated $310K sold.

Marshall Wace North America first reported a position in SCSC in Q1 2018 and held it in 2 quarters. The position peaked at $472K in Q1 2018. 169 funds tracked by Wall St. Rank hold SCSC as of Q3 2018.

Marshall Wace North America reported no remaining Scansource position as of Q3 2018 after selling out during the quarter.
Marshall Wace North America sold 7,688 Scansource shares in Q3 2018, an estimated $310K.
Marshall Wace North America first reported a position in Scansource in Q1 2018 and held it in 2 quarters.
Marshall Wace North America's Scansource position peaked at $472K in Q1 2018.
169 funds tracked by Wall St. Rank held Scansource as of Q3 2018.

Based on Marshall Wace North America's 13F filing for Q3 2018, filed 14 Nov 2018.